We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
KRONOS Worldwide
KRO
$989M
| $732K | ﹤0.01% |
63,536
-72,517
| -53% | -$977K |
|
1627
S&T Bancorp
STBA
$1.79B
| $732K | ﹤0.01% |
19,338
-13,993
| -42% | -$564K |
|
|
ENV
1628
DELISTED
ENVESTNET, INC.
ENV
| $732K | ﹤0.01% |
14,875
-287
| -2% | -$15.4K |
|
1629
iRhythm Holdings
IRTC
$4.2B
| $730K | ﹤0.01% |
10,501
-1,519
| -13% | -$115K |
|
1630
US Physical Therapy
USPH
$1.22B
| $730K | ﹤0.01% |
7,132
+1,506
| +27% | +$167K |
|
1631
Atara Biotherapeutics
ATRA
$76.1M
| $729K | ﹤0.01% |
840
-24
| -3% | -$22.3K |
|
1632
Diodes
DIOD
$4.84B
| $725K | ﹤0.01% |
22,475
-35,542
| -61% | -$1.14M |
|
|
MAXR
1633
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $725K | ﹤0.01% |
+60,654
| New | +$1.23M |
|
|
CSGS
1634
DELISTED
CSG Systems International
CSGS
| $724K | ﹤0.01% |
22,774
-2,081
| -8% | -$73.1K |
|
1635
Mercer International
MERC
$39.8M
| $723K | ﹤0.01% |
69,259
+35,892
| +108% | +$499K |
|
1636
Sabra Healthcare REIT
SBRA
$5.37B
| $723K | ﹤0.01% |
+43,890
| New | +$884K |
|
1637
Fox Factory Holding Corp
FOXF
$886M
| $716K | ﹤0.01% |
12,162
+3,038
| +33% | +$189K |
|
1638
Ovintiv
OVV
$16.4B
| $712K | ﹤0.01% |
24,690
-95,360
| -79% | -$4.11M |
|
1639
Artisan Partners
APAM
$3.02B
| $708K | ﹤0.01% |
32,027
-7,173
| -18% | -$191K |
|
1640
Biglari Holdings Class B
BH
$1.21B
| $706K | ﹤0.01% |
6,212
-10,176
| -62% | -$1.5M |
|
1641
Yelp
YELP
$1.41B
| $704K | ﹤0.01% |
20,126
-304,803
| -94% | -$11.6M |
|
1642
Methode Electronics
MEI
$592M
| $701K | ﹤0.01% |
30,118
-40,997
| -58% | -$1.16M |
|
|
CBM
1643
DELISTED
Cambrex Corporation
CBM
| $699K | ﹤0.01% |
18,512
+1,209
| +7% | +$61.2K |
|
1644
WSFS Financial
WSFS
$4.15B
| $697K | ﹤0.01% |
18,378
-4,431
| -19% | -$187K |
|
|
MNDT
1645
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $695K | ﹤0.01% |
+42,867
| New | +$770K |
|
1646
Laureate Education
LAUR
$5.28B
| $694K | ﹤0.01% |
+45,565
| New | +$682K |
|
1647
Alpha and Omega Semiconductor
AOSL
$1.08B
| $693K | ﹤0.01% |
68,023
-158,952
| -70% | -$1.64M |
|
1648
Q2 Holdings
QTWO
$3.92B
| $689K | ﹤0.01% |
13,908
-984
| -7% | -$50.2K |
|
1649
BlackLine
BL
$1.72B
| $688K | ﹤0.01% |
16,803
+10,119
| +151% | +$430K |
|
1650
MGP Ingredients
MGPI
$375M
| $687K | ﹤0.01% |
12,049
-13,722
| -53% | -$926K |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.